Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 4otq.1

Crystal structure of BTK kinase domain complexed with 1-[5-[3-(7-tert-butyl-4-oxo-quinazolin-3-yl)-2-methyl-phenyl]-1-methyl-2-oxo-3-pyridyl]-3-methyl-urea

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.55 Å
Oligo State
monomer
Ligands
1 x 2V2: 1-{5-[3-(7-tert-butyl-4-oxoquinazolin-3(4H)-yl)-2-methylphenyl]-1-methyl-2-oxo-1,2-dihydropyridin-3-yl}-3-methylurea(Non-covalent)
2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Lou, Y. et al., Structure-Based Drug Design of RN486, a Potent and Selective Bruton's Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis. J.Med.Chem. (2015)
Release Date
2014-05-14
Peptides
Tyrosine-protein kinase BTK: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence

4ot5.1 | 4ot6.1 | 4otr.1 | 4rfy.1 | 4rfz.1 | 4rg0.1 | 6ep9.1 | 6hrp.1 | 6hrt.1